Biotin-PEG6-Thalidomide

 CAS No.: 2144775-48-2  Cat No.: BP-500129 4.5  

Biotin-PEG6-Thalidomide is a heterobifunctional PROTAC linker in which a thalidomide cereblon-recruiting ligand is connected through a polyethylene glycol spacer to a biotin handle. Structurally, it contains a flexible PEG chain of moderate length that serves as a solubilizing, distance-defining element, while the biotin moiety enables strong, specific capture or immobilization on streptavidin/avidin surfaces for assay development or workflow integration. In PROTAC design, the thalidomide portion engages the E3 ubiquitin ligase substrate receptor cereblon, positioning the conjugated partner for ubiquitination and subsequent proteasomal degradation. The PEG spacer helps mitigate steric hindrance and can improve productive ternary complex formation, whereas the biotin tag facilitates tethering to solid supports, affinity enrichment, or surface-based readouts. This reagent is valuable for targeted protein degradation research requiring robust immobilization, controlled conjugation strategies, and improved experimental throughput in mechanistic and screening studies.

Biotin-PEG6-Thalidomide

Structure of 2144775-48-2

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
PROTAC Linker
Molecular Formula
C₃₇H₅₃N₅O₁₂S
Molecular Weight
791.91

* For research and manufacturing use only. Not for human or clinical use.

SizePriceStockQuantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

  • Comprehensive PROTAC Platform
  • Scientific Expertise & Technical Support
  • Custom Synthesis & Design Service
  • Extensive Product Coverage
  • Cutting-Edge Innovation
  • Fast Delivery & Global Support
  • 24/7 customer service
  • 100% quality assurance
Popular Publications Citing BOC Sciences Products
Solubility
In DMSO: 100 mg/mL (126.28 mM; Need ultrasonic)
Storage
Pure form, -20°C, 3 years; In solvent, -80°C, 6 months; -20°C, 1 month
Shipping
Room temperature in continental US; may vary elsewhere.
IUPACName
5-[(3aR,4R,6aS)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[2-[2-[2-[2-[2-[2-[2-[3-(1,3-dioxoisoindol-2-yl)-2,6-dioxopiperidin-1-yl]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]pentanamide
InChI Key
UCCXTWDQIINXHE-QSCAEMQVSA-N
InChI
InChI=1S/C37H53N5O12S/c43-31(8-4-3-7-30-33-28(25-55-30)39-37(48)40-33)38-11-13-49-15-17-51-19-21-53-23-24-54-22-20-52-18-16-50-14-12-41-32(44)10-9-29(36(41)47)42-34(45)26-5-1-2-6-27(26)35(42)46/h1-2,5-6,28-30,33H,3-4,7-25H2,(H,38,43)(H2,39,40,48)/t28-,29?,30-,33-/m1/s1
SMILES
C1CC(=O)N(C(=O)C1N2C(=O)C3=CC=CC=C3C2=O)CCOCCOCCOCCOCCOCCOCCNC(=O)CCCCC4C5C(CS4)NC(=O)N5
ConcentrationVolumeMass1 mg5 mg10 mg
1 mM1.2628 mL6.3138 mL12.6277 mL
5 mM0.2526 mL1.2628 mL2.5255 mL
10 mM0.1263 mL0.6314 mL1.2628 mL

Biotin-PEG6-Thalidomide is a bifunctional PROTAC linker component designed to couple a biotin-based handle to a cereblon-recruiting thalidomide moiety through a flexible polyethylene glycol spacer. Its PEG architecture supports productive ternary complex formation by improving solubility and conformational adaptability, while the biotin functionality enables affinity-based detection or enrichment workflows. The molecule is therefore well suited for constructing targeted protein degradation systems; detailed structural and synthetic considerations follow below.

Structure: The linker comprises a polyethylene glycol chain that provides a flexible, hydrophilic scaffold, connecting a biotin-derived binding motif to a thalidomide-derived cereblon ligand. It contains amide and ether linkages typical of PEG-based conjugates, enabling stable covalent connectivity and favorable aqueous compatibility.

Reactivity: This component is used as a prefunctionalized PROTAC building block in conjugation strategies that preserve the cereblon-binding pharmacophore. Suitable assembly commonly relies on chemoselective coupling of the biotin end to complementary handles (e.g., activated esters or maleimides) under mild aqueous or mixed-solvent conditions, with reaction monitoring to avoid degradation of the thalidomide motif and to maintain linker integrity.

Stock concentration: *
Desired final volume: *
Desired concentration: *

L

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2

* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O c22h30n40
g/mol
g

Related Product Recommendations

BOC Sciences Support

Please contact us with any specific requirements and we will get back to you as soon as possible.


  • Verification code

We invite you to contact us at or through our contact form above for more information about our services and products.

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
Germany
Inquiry Basket